{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:47:49Z","timestamp":1770450469263,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.autrev.2017.07.015","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T17:01:44Z","timestamp":1501693304000},"page":"995-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["\u201cHow I treat\u201d autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis"],"prefix":"10.1016","volume":"16","author":[{"given":"Dario","family":"Roccatello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.07.015_bb0005","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.autrev.2017.07.014","article-title":"How I treat juvenile idiopathic arthritis: a state of the art review","volume":"16","author":"Cimaz","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0010","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.autrev.2017.07.018","article-title":"How I treat patients with systemic sclerosis in clinical practice","volume":"16","author":"Rossi","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0015","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.autrev.2017.07.016","article-title":"How I treat idiopathic patients with inflammatory myopathies in the clinical practice","volume":"16","author":"Cavagna","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0020","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2017.07.017","article-title":"How I treat patients with adult onset Still's disease in clinical practice","volume":"16","author":"Govoni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.autrev.2017.04.007","article-title":"Rituximab for immunologic renal disease: what the nephrologist needs to know","volume":"16","author":"Kronbichler","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2016.09.018","volume":"16","author":"Cottin","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0035","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.autrev.2016.03.007","article-title":"Pathogenesis of ANCA-associated vasculitis: an update","volume":"15","author":"Jarrot","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.autrev.2016.03.010","article-title":"Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)","volume":"15","author":"Csernok","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.015_bb0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2016.02.005","article-title":"Granulomatosis with polyangiitis and facial palsy: literature review and insight in the autoimmune pathogenesis","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2017.07.015_bb0050","doi-asserted-by":"crossref","first-page":"i59","DOI":"10.1136\/ard.2010.138024","article-title":"Pathogenesis of ANCA-associated vasculitides","volume":"70","author":"Kallenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.015_bb0055","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.38036","article-title":"Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis","volume":"65","author":"Xie","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.015_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.015_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.015_bb0070","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/ket381","article-title":"Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients","volume":"53","author":"Charles","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.07.015_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000329535","article-title":"Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis","volume":"34","author":"Roccatello","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.autrev.2017.07.015_bb0080","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.015_bb0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jca.21318","article-title":"Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression","volume":"29","author":"de Joode","year":"2014","journal-title":"J Clin Apher"},{"key":"10.1016\/j.autrev.2017.07.015_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.015_bb0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0000000000000020","article-title":"Granulomatosis with polyangiitis (Wegener's)","volume":"93","author":"Springer","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.07.015_bb0100","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.015_bb0105","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","article-title":"A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.015_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3899\/jrheum.110143","article-title":"Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis","volume":"39","author":"Roubaud-Baudron","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.015_bb0115","first-page":"S706","article-title":"Rituximab versus Azathioprine for maintenance in ANCA-associated vasculitis [abstract]","author":"Guillevin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.015_bb0120","first-page":"5","article-title":"The \u201c4 plus 2\u201d rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: a 10years observation study","author":"Roccatello","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2017.07.015_bb0125","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.autrev.2015.07.017","article-title":"A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-clinical response compared to literature and immunological re-assessment","volume":"14","author":"Roccatello","year":"2015","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T23:49:01Z","timestamp":1569973741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1568997217301982"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.015","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cHow I treat\u201d autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}